ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients

Conclusion: Immune assessment resulted in favorable anakinra responses among critically ill patients with COVID-19 and features of MALS.J Innate Immun
Source: Journal of Innate Immunity - Category: Allergy & Immunology Source Type: research